Dr. Kristie A. Bobolis
Claim this profileAlta Bates Summit Medical Center-Herrick Campus
Studies Breast Cancer
Studies Cancer
10 reported clinical trials
27 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
PR positive
2Cancer
HER2 positive
ER positive
PR positive
Affiliated Hospitals
Clinical Trials Kristie A. Bobolis is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Kristie A. Bobolis
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Kristie A. Bobolis has experience with
- Paclitaxel
- Atezolizumab
- Questionnaire Administration
- Biospecimen Collection
- Trastuzumab
- Pertuzumab
Breakdown of trials Kristie A. Bobolis has run
Breast Cancer
Cancer
Colorectal Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kristie A. Bobolis specialize in?
Kristie A. Bobolis focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Kristie A. Bobolis currently recruiting for clinical trials?
Yes, Kristie A. Bobolis is currently recruiting for 6 clinical trials in Berkeley California. If you're interested in participating, you should apply.
Are there any treatments that Kristie A. Bobolis has studied deeply?
Yes, Kristie A. Bobolis has studied treatments such as Paclitaxel, Atezolizumab, Questionnaire Administration.
What is the best way to schedule an appointment with Kristie A. Bobolis?
Apply for one of the trials that Kristie A. Bobolis is conducting.
What is the office address of Kristie A. Bobolis?
The office of Kristie A. Bobolis is located at: Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California 94704 United States. This is the address for their practice at the Alta Bates Summit Medical Center-Herrick Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.